Open Actively Recruiting

A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)

About

Brief Summary

A study to assess the safety and efficacy of K-321 in participants with FECD after descemetorhexis.

Primary Purpose
Treatment
Study Type
Interventional
Phase
Phase III

Eligibility

Gender
All
Healthy Volunteers
No
Minimum Age
18 Years
Maximum Age
N/A

Inclusion Criteria:

  • Is at least 18 years old at the screening visit (Visit 1)
  • Has a diagnosis of FECD at Visit 1
  • Meets all other inclusion criteria outlined in clinical study protocol

Exclusion Criteria:

  • Is a female patient of childbearing potential and any of the following is true:
    • is pregnant or lactating/breastfeeding, or
    • is not surgically sterile, not post-menopausal (no menses for the previous 12 months), or not practicing an effective method of birth control as determined by the Investigator (eg, oral contraceptives, double barrier methods, hormonal injectable or implanted contraceptives, tubal ligation, or partner with vasectomy)
  • Has a study eye with a history of cataract surgery within 90 days of Visit 1
  • Meet any other exclusion criteria outlined in clinical study protocol

Join this Trial

Contact our clinical trial navigators for opportunities that may be suitable for you
Share:
Study Stats
Protocol No.
23-5047
Category
Eye/Ocular Disorders
Contact
Rubi Arias
Location
  • UCLA Westwood
For Providers
NCT No.
NCT05795699
For detailed technical eligibility, visit ClinicalTrials.gov.